quote:Originally posted by invester: A little early on my call. $1.16 pre-market. Up almost 100% today. Amazing numbers. This should be $5 soon.
I need to look at their filings again. Last I checked they were rated "worthless" by i think fitch? Not saying impossible but certainly they have their work cut out for them. I need to do some homework invester. This week certainly has been interesting though!
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!?
IP: Logged |
posted
While Ambac does not believe that the Segregated Account Rehabilitation Proceedings constitute an event of default under its debt indentures, debt holders may assert that the Segregated Account Rehabilitation Proceedings constitute an event of default and may seek to accelerate the debt. In addition, Ambac may consider, among other things, a negotiated restructuring of its outstanding debt through a prepackaged bankruptcy proceeding or may seek bankruptcy protection without agreement concerning a plan of reorganization with major creditor groups. No assurance can be given that Ambac will be successful in executing any or all of these strategies. While management believes that Ambac will have sufficient liquidity to satisfy its needs through the second quarter of 2011, no guarantee can be given that it will be able to pay all of its operating expenses and debt service obligations thereafter, and its liquidity may run out prior to the second quarter of 2011. Further, Ambac may decide prior to the third quarter of 2010 not to pay interest on its debt.
The Segregated Account Rehabilitation is a pretty interesting strategy. I won't repost the whole 10k and maybe invester sees things much differently than I do. Gonna take some massive dilution to move forward imo. Maybe I see the glass half empty. http://www.sec.gov/Archives/edgar/data/874501/000119312510080450/d10k.htm
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!?
IP: Logged |
quote:Originally posted by invester: I sold half at 100%, as I always do, then let the rest run. It looks as if that half is running into the ground. LoL.
Yeah but it has the herds attention so could easily bounce back up again imo, i'm not watching the chart on it, just the price action, fkn nuts imo. Good job on the gain!! Watching RPC and RNN also
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!?
IP: Logged |
quote:Originally posted by BooDog: a group on google is researching RPC, says their testing method is pretty much worthless. I haven't done any real DD yet.
Worthless? I'm going to look into it as well. Let me know what you come up with?
IP: Logged |
posted
PR just hit. So between the 2 convertibles its about 8 million shares. They only have 17 million out though. Tus almost 50% dilution. The O’S would still be low. If there testing method is good, this will rock.
Radient Pharma Completes Second Closing of Convertible Promissory Note Financing
{"s" : "rpc","k" : "c10,l10,p20,t10","o" : "","j" : ""} Press Release Source: Radient Pharmaceuticals Corporation On Tuesday April 13, 2010, 4:25 pm TUSTIN, CA--(Marketwire - 04/13/10) - US-based pharmaceutical company Radient Pharmaceuticals Corporation (AMEX:RPC - News) announced today the second closing of a 12% Convertible Promissory Note ("Note") and Warrant ("Warrant") financing for the sale of additional Notes in the aggregate principal amount of $5,524,425. The first financing, which closed on March 26, 2010, included one Note in the original principal amount of $925,000 and Warrants to purchase up to 1,100,000 shares of RPC common stock. Net proceeds for the first financing were approximately $540,000.
The second Convertible Promissory Note financing was offered to 25 accredited investors with similar discount terms and lender fees to that of the first financing. Net proceeds from the sale of Notes in second closing after payment of fees and discounts were approximately $3,225,000. Warrants to purchase 6,569,585 shares of RPC common stock were also issued as a part of the second closing.
Under the terms of the second financing agreement, lenders have the option to convert the Notes in whole or in part into shares of RPC common stock at a conversion price equal to 80% of volume-weighted average price for the five trading days ending on the business day immediately preceding the applicable date of conversion with a floor price initially equal to $0.38 per share. The Notes are subject to adjustment upon the occurrence of certain events, including recapitalization, stock splits, and similar corporate actions. The Warrants have a term of five years and are initially exercisable at $.38 per share. The exercise price is subject to adjustment upon the occurrence of certain events, including capital adjustments and reorganizations.
Radient Pharmaceuticals intends to use net proceeds from the first and second finance closings for general corporate purposes. Finder fees aggregating approximately $419,250 were issued at the closing for this transaction.
For additional information on Radient Pharmaceuticals, ADI and its portfolio of products, visit the Company's corporate website at http://www.Radient-Pharma.com/. For Investor Relations information contact Kristine Szarkowitz at kszarkowitz@Radient-Pharma.com or 1.206.310.5323.
About Radient Pharmaceuticals: Headquartered in Tustin, California, Radient Pharmaceuticals Corporation is an integrated pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic and premium skin care products.
IP: Logged |
quote:Originally posted by invester: PR just hit. So between the 2 convertibles its about 8 million shares. They only have 17 million out though. Tus almost 50% dilution. The O’S would still be low. If there testing method is good, this will rock.
quote:Originally posted by invester: PR just hit. So between the 2 convertibles its about 8 million shares. They only have 17 million out though. Tus almost 50% dilution. The O’S would still be low. If there testing method is good, this will rock.
My call is that they will dilute like a bandit, looks like they are a late filer also so maybe we'll see things more clearly when they file.
I have no intention of starting a RPC thread invester but just had to share this... RPCAMDL INC (RPC) Pre-Market Trading Pre-Market Charts | After Hours Charts Apr. 13, 2010 Market Close: $ 1.70 Pre-Market Last: $ 1.35 Pre-Market High: $ 1.62 Pre-Market Volume: 210,529 Pre-Market Low: $ .28
blame it all on the low float eh?
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!?
IP: Logged |